Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy

Vaisman, Fernanda, Momesso, Denise, Bulzico, Daniel A., Pessoa, Cencita H. C. N., Dias, Fernando, Corbo, Rossana, Vaisman, Mário, Tuttle, R. Michael·2012·Clinical Endocrinology

Abstract

Summary: Objective: To validate the A merican T hyroid A ssociation (ATA) initial risk of recurrence scheme and the M emorial S loan K ettering C ancer C enter (MSKCC) response to therapy re‐stratification approach in a large cohort of patients with differentiated thyroid cancer (DTC) treated outside of the U nited S tates. Design: Retrospective chart review. Patients: Five hundred and six patients with DTC followed for a median of 10 years after total thyroidectomy and RAI remnant ablation at a major cancer centre in B razil. Measurements: Final clinical outcomes were assessed based on A merican J oint C ancer C ommittee (AJCC)/U nion I nternationale C ontre le C ancer (UICC) staging, ATA risk stratification and response to therapy assessment (excellent, acceptable, biochemical incomplete and structural incomplete). Results: The AJCC/UICC staging system did not adequately stratify patients with regard to the risk of recurrence/persistent disease. However, the ATA system demonstrated a 13% risk of recurrent/persistent disease in low‐risk patients, 36% in intermediate risk patients, and 68% in high‐risk patients. Furthermore, an excellent response to therapy decreased the risk of recurrent/persistent disease to 1·4%. At the time of final follow‐up, 34% of the biochemical incomplete response patients had been re‐classified as having no evidence of disease (NED) without having received any additional therapy beyond continue levothyroxine suppression. Conversely, even after additional therapies, only 9% of the patients with an incomplete structural response were eventually re‐classified as NED. Conclusions: These data validate the ATA risk classification as an excellent initial predictor of recurrent/persistent disease and confirm the clinical utility of the MSKCC dynamic risk assessment system in a cohort of patients evaluated and treated outside the U nited S tates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2012.04342.x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 267

Metadata

Authors
Vaisman, F., Momesso, D., Bulzico, D. A., Pessoa, C. H. C. N., Dias, F., Corbo, R., Vaisman, M., & Tuttle, R. M.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2012-06-06
Volume
77
Issue
1
Pages
132-138
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2034542445
Cited by
267
References
21
FWCI
9.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. https://app.cochat.ai/papers/10.1111/j.1365-2265.2012.04342.x
The paper
Vaisman, F., Momesso, D., Bulzico, D. A., Pessoa, C. H. C. N., Dias, F., Corbo, R., Vaisman, M., & Tuttle, R. M. (2012). Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2012.04342.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.